Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Chemical Research in Toxicology
|
December 2, 2015
Safety Lead Optimization and Candidate Identification: Integrating New Technologies into Decision-Making
Donna M Dambach, Dinah Misner, Mathew Brock, et al.
Circulation Research
|
October 11, 2019
Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms
Li Pang, Philip Sager, Xi Yang, et al.
Journal of Pharmacological and Toxicological Methods
|
November 21, 2017
Comparative analysis of media effects on human induced pluripotent stem cell-derived cardiomyocytes in proarrhythmia risk assessment
Derek Schocken, Jayna Stohlman, Jose Vicente, et al.
Scientific Reports
|
March 16, 2013
Deriving dopaminergic neurons for clinical use. A practical approach
Rodolfo Gonzalez, Ibon Garitaonandia, Tatiana Abramihina, et al.
Frontiers in Pharmacology
|
September 27, 2019
Considerations for an <i>In Vitro</i>, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Using Human iPSC-Cardiomyocytes
Alexandre J S Ribeiro, Brian D Guth, Michael Engwall, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
October 5, 2016
Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias
Ksenia Blinova, Jayna Stohlman, Jose Vicente, et al.
Cell Reports
|
September 27, 2018
International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment
Ksenia Blinova, Qianyu Dang, Daniel Millard, et al.
Cell Reports
|
December 3, 2014
iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease
Chris M Woodard, Brian A Campos, Sheng-Han Kuo, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Chemical Research in Toxicology
|
December 2, 2015
Safety Lead Optimization and Candidate Identification: Integrating New Technologies into Decision-Making
Donna M Dambach, Dinah Misner, Mathew Brock, et al.
Circulation Research
|
October 11, 2019
Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms
Li Pang, Philip Sager, Xi Yang, et al.
Journal of Pharmacological and Toxicological Methods
|
November 21, 2017
Comparative analysis of media effects on human induced pluripotent stem cell-derived cardiomyocytes in proarrhythmia risk assessment
Derek Schocken, Jayna Stohlman, Jose Vicente, et al.
Scientific Reports
|
March 16, 2013
Deriving dopaminergic neurons for clinical use. A practical approach
Rodolfo Gonzalez, Ibon Garitaonandia, Tatiana Abramihina, et al.
Frontiers in Pharmacology
|
September 27, 2019
Considerations for an <i>In Vitro</i>, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Using Human iPSC-Cardiomyocytes
Alexandre J S Ribeiro, Brian D Guth, Michael Engwall, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
October 5, 2016
Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias
Ksenia Blinova, Jayna Stohlman, Jose Vicente, et al.
Cell Reports
|
September 27, 2018
International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment
Ksenia Blinova, Qianyu Dang, Daniel Millard, et al.
Cell Reports
|
December 3, 2014
iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease
Chris M Woodard, Brian A Campos, Sheng-Han Kuo, et al.
Page
of 1